Annual Accounts Receivable
N/A
31 December 2023
Summary:
Biohaven Pharmaceutical Holding annual accounts receivable is not available.BHVN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
N/A
30 September 2024
Summary:
Biohaven Pharmaceutical Holding quarterly accounts receivable is not available.BHVN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BHVN Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
BHVN Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Biohaven Pharmaceutical Holding Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $352.45 M(+7.3%) |
| Mar 2022 | - | $328.34 M(+6.5%) |
| Dec 2021 | $308.27 M(+156.7%) | - |
| Dec 2021 | - | $308.27 M(+21.9%) |
| Sept 2021 | - | $252.95 M(+50.0%) |
| June 2021 | - | $168.64 M(+7.6%) |
| Mar 2021 | - | $156.77 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $120.11 M(>+9900.0%) | - |
| Dec 2020 | - | $120.11 M(+51.0%) |
| Sept 2020 | - | $79.52 M(+77.5%) |
| June 2020 | - | $44.80 M(+932.9%) |
| Mar 2020 | - | $4.34 M(>+9900.0%) |
| Dec 2019 | $0.00 | - |
| Dec 2019 | - | $0.00 |
FAQ
- What is the all time high annual accounts receivable for Biohaven Pharmaceutical Holding?
- What is the all time high quarterly accounts receivable for Biohaven Pharmaceutical Holding?
What is the all time high annual accounts receivable for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high annual accounts receivable is $308.27 M
What is the all time high quarterly accounts receivable for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high quarterly accounts receivable is $352.45 M